Orchestra BioMed Holdings (OBIO) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 41.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.19 Mn |
| Dec 31, 2025 | 53.57 Mn |
| Sep 30, 2025 | 43.74 Mn |
| Jun 30, 2025 | 295,000.00 |
| Mar 31, 2025 | 16.86 Mn |
| Dec 31, 2024 | 32.96 Mn |
| Sep 30, 2024 | 46.22 Mn |
| Jun 30, 2024 | 44.13 Mn |
| Mar 31, 2024 | 57.19 Mn |
| Dec 31, 2023 | 68.04 Mn |
| Sep 30, 2023 | 79.66 Mn |
| Jun 30, 2023 | 89.44 Mn |
| Mar 31, 2023 | 99.75 Mn |
| Dec 31, 2022 | 52.53 Mn |
| Sep 30, 2022 | 61.43 Mn |
| Jun 30, 2022 | 69.51 Mn |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | -19.78 Mn |
| Sep 30, 2021 | -3.85 Mn |
| Jun 30, 2021 | -3.76 Mn |
| Mar 31, 2021 | -3.67 Mn |
| Dec 31, 2020 | -3.56 Mn |